Hyundai Pharmaceutical Co., Ltd. (KRX:004310)

Hyundai Pharmaceutical Ratios and Metrics

Market cap in millions KRW. Fiscal year is December - November.

Fiscal Year	Current	FY 2013	FY 2012	FY 2011	FY 2010	FY 2009
Period Ending	Jun 6, 2025	Nov 30, 2013	Nov 30, 2012	Nov 30, 2011	Nov 30, 2010	Nov 30, 2009
Market Capitalization	96,457	42,443	36,229	27,905	38,340	55,972
Market Cap Growth	17.15%	17.15%	29.83%	-27.22%	-31.50%	-0.39%
Enterprise Value	-	48,445	43,620	36,761	49,208	69,151
Last Close Price	3485.00	1585.87	1322.16	994.81	1321.64	1793.06
PE Ratio	57.76	30.00	-	53.65	12.92	33.50
PS Ratio	0.89	0.39	0.35	0.24	0.34	0.46
PB Ratio	0.95	0.42	0.36	0.27	0.41	0.60
P/TBV Ratio	0.98	0.43	0.37	0.28	0.42	0.61
P/FCF Ratio	16.89	7.43	-	10.79	-	-
P/OCF Ratio	12.13	5.34	-	4.45	14.32	-
EV/Sales Ratio	-	0.45	0.43	0.32	0.44	0.56
EV/EBITDA Ratio	-	11.27	-	6.20	35.00	18.32
EV/EBIT Ratio	-	22.15	-	10.62	-	59.08
EV/FCF Ratio	-	8.49	-	14.22	-	-
Debt / Equity Ratio	0.21	0.21	0.29	0.27	0.24	0.25
Debt / EBITDA Ratio	4.83	4.83	-	4.69	15.65	6.23
Debt / FCF Ratio	3.63	3.63	-	10.76	-	-
Asset Turnover	0.74	0.74	0.67	0.79	0.84	0.93
Inventory Turnover	3.00	3.00	3.07	4.41	4.42	4.89
Quick Ratio	1.62	1.62	1.41	1.55	1.80	1.64
Current Ratio	2.20	2.20	1.97	1.94	2.21	2.07
Return on Equity (ROE)	1.45%	1.45%	-4.75%	0.55%	3.21%	1.80%
Return on Assets (ROA)	0.93%	0.93%	-1.76%	1.50%	-0.42%	0.55%
Return on Capital (ROIC)	1.09%	1.09%	-2.07%	1.75%	-0.48%	0.64%
Return on Capital Employed (ROCE)	2.00%	2.00%	-	3.10%	-	1.20%
Earnings Yield	1.47%	3.33%	-13.39%	1.86%	7.74%	2.99%
FCF Yield	5.92%	13.45%	-11.47%	9.27%	-3.31%	-16.46%
Dividend Yield	0.86%	2.65%	-	-	3.40%	2.79%
Payout Ratio	62.32%	62.32%	-	202.97%	41.25%	95.71%
Buyback Yield / Dilution	-0.08%	-0.08%	0.90%	0.97%	2.94%	7.44%
Total Shareholder Return	0.78%	2.56%	0.90%	0.97%	6.34%	10.23%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.